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ABSTRACT 
Objective: To develop a simple and cheap UV spectrophotometric method for the simultaneous quantitative estimation of Mebeverine 
hydrochloride and Chlordiazepoxide in MEVA C Capsules and validate as per ICH guidelines.  
Methods: The optimized method uses triethylammonium phosphate buffer (pH 4.0) as a solvent for the estimation of assay of Mebeverine 
hydrochloride and Chlordiazepoxide in capsules at detection wavelengths of 263 nm and 245 nm respectively.  
Results: The developed method exhibited linearity in the range of 7.5-22.5μg/ml for Mebeverine hydrochlorideand 2.5-7.5μg/ml for 
Chlordiazepoxide. Precision for Mebeverine hydrochloride and Chlordiazepoxide is exemplified by relative standard deviation of 0.589% and 0.332 
respectively. Percentage Mean recovery for Mebeverine hydrochloride and Chlordiazepoxide was found to be in the range of 98-102, during 
accuracy studies. The limit of detection (LOD) for Mebeverine hydrochloride and Chlordiazepoxide was found to be 528ng/ml and 192ng/ml 
respectively, while limit of quantitiation (LOQ) for Mebeverine hydrochloride and Chlordiazepoxide was found to be 1.6µg/ml and 583ng/ml 
respectively.  
Conclusion: A simple and a cheap UV spectrophotometric method were developed and validated for the simultaneous quantitative estimation of 
Mebeverine hydrochloride and Chlordiazepoxide in capsules as per ICH guidelines and hence it can be used for the routine analysis in various 
pharmaceutical industries.  
Keywords: UV, Mebeverine hydrochloride, Chlordiazepoxide, Method development, Validation. 
 
Mebeverine hydrochloride (Figure 1) is a white crystalline powder 




HCl, molecular weight 466 
and melting point 105-107ºC. It is freely soluble in water and 
ethanol (96%), while practically insoluble in diethyl ether [1]. IUPAC 
name of Mebeverine hydrochloride is 3,4-Dimethoxybenzoic acid 4-
[ethyl[2-(4-methoxy phenyl)-1-methylethyl]amino]-butyl ester. It is 
a direct antispasmodic acting mainly on the smooth muscles of the 
gastrointestinal tract and particularly effective against the colonic 
spasm [2]. Mebeverine hydrochloride is widely used as a relaxant 
agent for the treatment of gastrointestinal spasmodic disorders such 
as irritable bowel syndrome [3]. 
 
Fig. 1: Structure of Mebeverine hydrochloride 
 
Chlordiazepoxide (Figure 2) is a first among the class of 
benzodiazepines to be used clinically as anti-anxiety drug[4]. 
Chlordiazepoxide is a white crystalline powder possessing solubility 
in water, whose IUPAC name is (7-chloro-2(methylamino)-5-phenyl-
3-H-1,4 benzodiazepine 4-oxide). Chlordiazepoxide mainly acts on 
limbic system and ascending reticular formation in the central 
nervous system. It binds to stereospecific benzodiazepine binding 
sites on GABA receptor complexes at several sites within the central 
nervous system including the limbic system and reticular formation. 
The binding will facilitates GABA mediated chloride channel opening 
and produce hyperpolarisation. This will increase the concentration 
of inhibitory neurotransmitter GABA and chloride ions in the CNS 
and decreases firing rate of neurons[5]. Mebeverine hydrochloride 
(135mg) and Chlordiazepoxide (5mg) is commercially available as 
capsules (trade name: MEVA C). 
 
Fig. 2: Structure of Chlordiazepoxide 
 
A detailed literature survey reveals that there exists literature 
concerning analytical method development and validation for 
individual drugs Mebeverine[1,3,6-7] and Chlordiazepoxide[8-13] in 
various matrices. Also analytical methods are reported for 
Mebeverine with other drug combinations[2,14-19] and similarly 
Chlordiazepoxide with other drug combinations[4,20-23]. While 
there is only one literature reported on UV spectrophotometric 
method development and validation for the simultaneous 
quantitative estimation of Mebeverine and Chlordiazepoxide as drug 
combination in pharmaceutical dosage forms[24]. Hence we have 
explored in developing a new, accurate, precise and linear UV 
spectrophotometric method for the quantitative estimation of 
Mebeverine and Chlordiazepoxide in MEVA C capsules and validate 
as per ICH guidelines. 
MATERIALS AND METHODS 
Materials 
Instrument 
A double beam UV-visible spectrophotometer (Shimadzu, model 
1800) having two matched quartz cells with 1 cm light path and 
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loaded with UV probe software (version 2.41) was used for 
recording of spectra and measuring absorbance. An electronic 
weighing analytical balance (0.1mg sensitivity, Shimadzu AY 220), 
digital pH meter (DELUX model 101) and a sonicator (sonica, model 
2200 MH) were used in this study.  
Chemicals and Reagents 
Analytically pure samples of Mebeverine hydrochloride and 
Chlordiazepoxide with purities greater than 99% were obtained as 
gift samples from Chandra labs, Hyderabad, India and tablet 
formulation [MEVA C] was procured from MEDPLUS, Hyderabad, 
India with labelled amount 135mg of Mebeverine hydrochloride and 
5mg of Chlordiazepoxide. Triethylamine (AR Grade) and ortho 
phosphoric acid (AR Grade) were obtained from SD Fine chemicals 
(Hyderabad, India). 0.45μm Nylon membrane filters were obtained 
from Spincotech Private Limited, Hyderabad, India. 
Methods 
Solvent 
Solvent used is prepared by adding 5 ml of triethylamine to 1000 ml 
of distilled water and later pH was adjusted to 4.0 using 30% v/v of 
ortho phosphoric acid in water.  
Selection of suitable detection wavelength 
Suitable wavelength for Mebeverine hydrochloride and 
Chlordiazepoxide for the total experiment was determined by 
recording UV spectrums in the range of 200-400 nm and suitable 
wavelength for Mebeverine hydrochloride and Chlordiazepoxide was 
considered as 263 nm and 245 nm respectively. (Figure 3 and 4).  
 
 
Fig. 3: UV spectrum of standard Mebeverine hydrochloride. 
 
 
Fig. 4: UV spectrum of standard Chlordiazepoxide. 
 
Preparation of stock and working standard solution for 
mebeverine hydrochloride 
10mg of Mebeverine hydrochloride was accurately weighed and 
taken in 100 ml clean and dry volumetric flask containing 80 ml of 
solvent and then the solution was made up to the mark using the 
solvent. This is considered as the standard stock solution 
(100µg/ml). 1.5 ml of the stock solution was pipetted out and made 
up to 10 ml to get a concentration 15µg/ml, treated as working 
standard, 100% target concentration.  
Preparation of stock and working standard solution for 
chlordiazepoxide 
10mg of Chlordiazepoxide was accurately weighed and taken in 100 
ml clean and dry volumetric flask containing 80 ml of solvent and 
then the solution was made up to the mark using the solvent. This is 
considered as the standard stock solution (100µg/ml). 0.5 ml of the 
stock solution was pipetted out and made up to 10 ml to get a 
concentration 5µg/ml, treated as working standard, 100% target 
concentration.  
Preparation of stock and working sample solution for 
mebeverine hydrochloride 
Ten capsules were opened and only white powders in it were 
weighed separately and the average weight was determined. The 
average weight was transferred to a 100 ml volumetric flask 
containing 100 ml diluent and then stirred for 10 minutes, followed 
by filtration through 0.45µ nylon membrane filter to get sample 
stock solution of 1.35mg/ml. 0.11 ml of the above stock solution was 
pipetted out and made up to 10 ml to get working sample solution 
equivalent to a concentration of working standard of 15µg/ml. 
Preparation of stock and working sample solution for 
chlordiazepoxide 
Ten capsules were opened and only tablets in it were weighed 
separately and the average weight was determined. Ten tablets 
present in ten capsules were grinded in a pestle and mortar and the 
average weight was transferred to a 100 ml volumetric flask 
containing 100 ml diluent and then stirred for 10 minutes, followed 
by filtration through 0.45µ nylon membrane filter to get sample 
stock solution of 50µg/ml. 1 ml of the above stock solution was 
pipetted out and made up to 10 ml to get working sample solution 
equivalent to a concentration of working standard of 5 µg/ml. 
RESULTS AND DISCUSSION 
Method development 
Various buffers were explored (inorganic and organic based) as 
solvents, including Potassium dihydrogen orthophosphate, 
triethylammonium phosphate and ammonium acetate buffers 
varying pH in the ranges of 2-7. Mebeverine hydrochloride and 
Chlordiazepoxide were found to be soluble and stable for minimum 
of 1 hour at room temperature using pH 4.0 triethylammonium 
phosphate buffer and hence this buffer was used for the 
determination of suitable detection wavelength and working 
concentration of both drugs. In order to test the applicability of the 
developed method to a commercial formulation, MEVA C was 
studied at working concentration. Assay at working concentration 
for both the samples in the formulation was in acceptance limits (98-
102%) during extraction of drugs in the samples using the solvent 
for 10 minutes. The protocol affords reproducible quantification of 
the drugs in the samples ranging between 98 and 102%, which is the 
standard level in any pharmaceutical quality control. Hence the 
method is optimized. Figures 5 and 6 represent UV spectrums of the 




Fig. 5: UV spectrum of Mebeverine hydrochloride (white 
powder) of the sample. 
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Fig. 6: UV spectrum of Chlordiazepoxide (tablet) of the sample. 
 
Method validation 
Validation of the analytical method is the process that establishes by 
laboratory studies in which the performance characteristics of the 
method meet the requirements for the intended analytical 
application. UV spectrophotometric method developed was 
validated according to International Conference on Harmonization 
(ICH) guidelines [25] for validation of analytical procedures. The 
method was validated for the parameters like linearity, accuracy, 
system precision, intra-day precision, inter-day precision/ 
intermediate precision/ ruggedness, robustness, limit of detection 
(LOD) and limit of quantitiation (LOQ). 
Precision 
System precision 
Six replicate recording of absorbances for both the drugs at working 
concentration showed % RSD (Relative Standard Deviation) less 
than 2, which indicates the acceptable reproducibility and thereby 
the precision of the system. System precision results are tabulated in 
Table 1. 
Method precision 
Method precision was determined by performing assay of both the 
drugs in the formulation under the test of repeatability (Intra day 
precision) at working concentration.  
Repeatability (Intra day precision) 
Six replicate recording of absorbances for both the samples in the 
formulation from the same homogeneous mixture at working 
concentration showed % RSD less than 2 concerning % assay for the 
drugs which indicate that the method developed is method precise 
by the test of repeatability and hence can be understood that the 
method gives consistently reproducible results (Table 2). 
 
Table 1: System precision results (UV absorbance) of 
Mebeverine and Chlordiazepoxide 
 n  Mebeverine hydrochloride Chlordiazepoxide 
 263 nm 245 nm 
1 0.407 0.431 
2 0.411 0.430 
3 0.413 0.428 
4 0.409 0.430 
5 0.412 0.432 
 Average 0.410  0.4302 
 SD 0.0024  0.0014 
 % RSD 0.585  0.3254 
 
Table 2: Intra day precision results of Mebeverine 
hydrochloride and Chlordiazepoxide 
n Mebeverine 
HCl (263 nm) 
Chlordiazepoxide 
245 nm 
 % Assay % Assay 
1 100.79 99.00 
2 99.81 99.23 
3 99.32 99.69 
4 100.29 99.23 
5 99.56 99.77 
Average 99.95 99.38 
S. D. 0.589 0.330 
% RSD 0.589 0.332 
 
Linearity 
Standard solutions of Mebeverine hydrochloride and 
Chlordiazepoxide at different concentrations level (50%, 75%, 
100%, 125%, and 150%) were prepared in triplicates. Calibration 
curves were constructed by plotting the concentration level versus 
corresponding absorbance for both the drugs. The results show an 
excellent correlation between absorbance and concentration level 
within the concentration range of 7.5-22.5µg/ml for Mebeverine 
hydrochloride and 2.5-7.5µg/ml for Chlodiazepoxide (Tables 3 and 
4). The correlation coefficients were greater than 0.99 for both the 
drugs, which meet the method validation acceptance criteria and 
hence the method is said to be linear for both the drugs. 
 
Table 3: Calibration data for Mebeverine hydrochloride (263 nm) 








50 07.50 0.204 0.210 0.209 
75 11.25 0.282 0.286 0.278 
100 15.00 0.413 0.410 0.412 
125 18.75 0.495 0.490 0.489 
150 22.50 0.598 0.591 0.588 
Regression equation  y=0.026x-0.002 y=0.025x+0.011 y=0.025x+0.0076 
Regression coefficient  0.994 0.995 0.991 
  
Table 4: Calibration data for Chlordiazepoxide (245 nm) 








50 2.5 0.209 0.214 0.209 
75 3.75 0.327 0.322 0.325 
100 5 0.432 0.430 0.435 
125 6.25 0.527 0.531 0.536 
150 7.5 0.630 0.645 0.653 
Regression equation  y=0.083x-0.0101 y=0.085x-0.0098 y=0.086x-0.001 
Regression coefficient  0.999 0.997 0.999 
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Accuracy 
Accuracy was determined by means of recovery experiments, by the 
determination of % mean recovery of both the drugs in the 
formulation at three different levels (50-150%). At each level, three 
determinations were performed. Percent mean recovery and %RSD 
between recoveries are calculated as shown in Table 5. The accepted 
limits of mean recovery are 98% -102% and %RSD not more than 
2% and all observed data were within the required range, which 
indicates good recovery values and hence the accuracy of the 
method developed. 
 
Table 5: Results of Accuracy studies for Mebeverine 
hydrochloride and Chlordiazepoxide 
Concentration 
level (%) 
% Mean Recovery 
Mebeverine HCl 
% Mean Recovery 
Chlordiazepoxide 
50 100.67 98.97 
100 99.95 99.38 
150 101.02 99.78 
 
Robustness 
The robustness of an analytical method is a measure of its capacity to 
remain unaffected by small but deliberate variations in method 
parameters and provides an indication of its reliability during normal 
usage. It is concluded that the method is robust as it is found that the % 
RSD is less than 2 regarding the determination of assays of both the 
drugs in the formulation, despite deliberate variations done concerning 
pH ± 0.2 and detection wavelength ± 2 nm (Tables 6 and 7). 
Sensitivity 
The sensitivity of measurement of Mebeverine hydrochloride and 
Chlordiazepoxide by use of the proposed method was estimated in 
terms of the limit of quantitation (LOQ) and limit of detection (LOD). 
LOQ and LOD were calculated by the use of the equations LOD = 3.3 
x N / B and LOQ = 10x N / B where N is the standard deviation of 
intercepts of calibration plots and B is the average of the slopes of 
the corresponding calibration plot. 
 
Table 6: Robustness results of Mebeverine hydrochloride sample 
Variation parameter Variation % mean Assay %RSD 
pH(± 0.2) 2.8 100.02 0.588 
 3.0 99.65 0.643 
 3.2 98.99 0.410 








 263 101.2 1.045 
 265 99.54 1.120 
 
Table 7: Robustness results of Chlordiazepoxide sample 
Variation parameter Variation % mean Assay %RSD  

















The limit of detection (LOD) for Mebeverine hydrochloride and 
Chlordiazepoxide were found to be 528ng/ml and 192ng/ml 
respectively, while limit of quantitiation (LOQ) for Mebeverine 
hydrochloride and Chlordiazepoxide were found to be 1.6µg/ml and 
583ng/ml respectively. Optical characteristics and validation 
parameters results are summarized in Table 8. 
 
Table 8: Optical characteristics and validation parameters 
Parameters Mebeverine hydrochloride Chlordiazepoxide 
Detection wavelength (nm) 263 245  
Beer’s Law limits (µg/ml) 7.5-22.5  2.5-7.5  
Sandell’s sensitivity (µg/cm2 0.1 /0.001 absorbance unit) 0.01 
Regression equation (y = mx+c) (y y=0.025x+0.0055 Y=0.084x+0.0069 
Correlation coefficient (r2 0.993 ) 0.999 
Slope (m) 0.025 0.084 
Intercept (c) 0.0055 0.0069 
(% RSD) System precision 0.585 0.325 
(% RSD) Intra-day precision 0.589 0.332 
(% RSD) Inter-day precision ≤2 ≤2 
Accuracy (% Mean Recovery)   
 50 % Level 100.67 98.97 
 100 % Level 99.95 99.38 
 150 % Level 101.02 99.78 
LOD (µg/ml) 0.528 0.192  
LOQ (µg/ml) 1.6  0.583  
Robustness   
pH(± 0.2) (% RSD) ≤2 ≤2 
Wavelength (± 2 nm) (% RSD)  ≤2 ≤2 
 
CONCLUSION 
A cheap and a rapid UV spectrophotometric method was developed 
and validated for the quantitative estimation of Mebeverine 
hydrochloride and Chlordiazepoxide in capsules as per ICH 
guidelines. The developed method exhibited linearity in the range of 
7.5-22.5μg/ml for Mebeverine hydrochloride and 2.5-7.5μg/ml for 
Chlordiazepoxide.  
The precision for Mebeverine hydrochloride and Chlordiazepoxide is 
exemplified by relative standard deviation of 0.589% and 0.322 
respectively.  
Percentage Mean recovery for Mebeverine hydrochloride and 
Chlordiazepoxide were found to be in the range of 98-102, during 
accuracy studies. The limit of detection (LOD) for Mebeverine 
hydrochloride and Chlordiazepoxide were found to be 528ng/ml 
and 192ng/ml respectively, while limit of quantitiation (LOQ) for 
Mebeverine hydrochloride and Chlordiazepoxide were found to be 
1.6µg/ml and 583ng/ml respectively. Accordingly it is concluded 
that the developed UV spectrophotometric method is accurate, 
precise, linear, rugged and robust and therefore the method can be 
used for the routine analysis of Mebeverine hydrochloride and 
Chlordiazepoxide in capsules in various pharmaceutical industries. 
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